AARTIPHARM

Aarti Pharmalabs Share Price

₹737.00 +25.05 (3.52%)

24 Apr, 2025 06:46

SIP TrendupStart SIP in AARTIPHARM

Start SIP

Performance

  • Low
  • ₹706
  • High
  • ₹744
  • 52 Week Low
  • ₹488
  • 52 Week High
  • ₹837
  • Open Price₹716
  • Previous Close₹712
  • Volume460,224

Investment Returns

  • Over 1 Month -3.17%
  • Over 3 Month + 15.35%
  • Over 6 Month + 25.1%
  • Over 1 Year + 42.9%
SIP Lightning

Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!

Invest Now

Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 26.8
  • PEG Ratio
  • 1
  • Market Cap Cr
  • 6,679
  • P/B Ratio
  • 3.6
  • Average True Range
  • 42.62
  • EPS
  • 27.51
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -7.53
  • RSI
  • 53.11
  • MFI
  • 50.88

Aarti Pharmalabs Financials

Aarti Pharmalabs Technicals

EMA & SMA

Current Price
₹737.00
+ 25.05 (3.52%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹717.62
  • 50 Day
  • ₹714.62
  • 100 Day
  • ₹693.30
  • 200 Day
  • ₹653.31

Resistance and Support

729.03 Pivot Speed
  • R3 789.87
  • R2 766.93
  • R1 751.97
  • S1 714.07
  • S2 691.13
  • S3 676.17

What's your outlook on Aarti Pharmalabs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aarti Pharmalabs Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. It caters to global markets, providing high-quality and innovative solutions for various therapeutic segments.

Aarti Pharmalabs has an operating revenue of Rs. 2,057.07 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 16% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 8% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 14% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 84 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 44 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-05 Quarterly Results, Dividend & Others To consider other business matters. per share(40%)Interim Dividend
2024-10-28 Quarterly Results
2024-08-05 Quarterly Results
2024-05-13 Audited Results & Final Dividend
2024-02-07 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-02-14 INTERIM Rs.2.50 per share(50%)Interim Dividend
2024-07-31 FINAL Rs.1.00 per share(20%)Final Dividend
2024-02-19 INTERIM Rs.2.00 per share(40%)Interim Dividend
View More

Aarti Pharmalabs F&O

Aarti Pharmalabs Shareholding Pattern

44.66%
3.93%
6.09%
8.64%
0%
30.39%
6.29%

About Aarti Pharmalabs

  • NSE Symbol
  • AARTIPHARM
  • BSE Symbol
  • 543748
  • Managing Director
  • Mr. Narendra J Salvi
  • ISIN
  • INE0LRU01027

Similar Stocks to Aarti Pharmalabs

Aarti Pharmalabs FAQs

Aarti Pharmalabs share price is ₹737 As on 24 April, 2025 | 06:32

The Market Cap of Aarti Pharmalabs is ₹6679.1 Cr As on 24 April, 2025 | 06:32

The P/E ratio of Aarti Pharmalabs is 26.8 As on 24 April, 2025 | 06:32

The PB ratio of Aarti Pharmalabs is 3.6 As on 24 April, 2025 | 06:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23